Health Care: Drugs

Impax Laboratories Inc (IPXL: NASDAQ)

$29.26 n/a | n/a%
06/24/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 860.47M 596.05M 511.50M 581.69M
Cost of Sales 439.43M 250.14M 276.86M 210.17M
Gross Operating Profit 421.04M 345.90M 234.65M 371.52M
Selling, General, and Administrative Expenses 201.29M 139.39M 120.29M 118.24M
Research & Development 76.98M 79.11M 68.85M 81.32M
Operating Income before D & A (EBITDA) 142.77M 127.40M 45.51M 171.96M
Depreciation & Amortization 68.64M 33.25M 35.35M 88.96M
Interest Income 1.04M 1.47M 1.30M 1.09M
Other Income - Net 16.03M 313.00K 152.45M -138.00K
Special Income / Charges -4.57M -5.33M -16.55M 0.00
Total Income Before Interest Expenses (EBIT) 86.64M 90.60M 147.36M 83.94M
Interest Expense 27.27M 43.00K 419.00K 632.00K
Pre-Tax Income 59.37M 90.56M 146.94M 83.31M
Income Taxes 20.37M 33.21M 45.68M 27.44M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 39.00M 57.35M 101.26M 55.87M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 39.00M 57.35M 101.26M 55.87M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 39.00M 57.35M 101.26M 55.87M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
43.56M 62.69M 117.80M 55.87M
Preferred Dividends
Net Income Available To Common 39.00M 57.35M 101.26M 55.87M
Basic EPS from Continuing Ops. 0.56 0.84 1.51 0.85
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.56 0.84 1.51 0.85
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.56 0.84 1.51 0.85
Basic Normalized Net Income/Share 0.63 0.92 1.76 0.85
EPS fr Continuing Ops. 0.54 0.81 1.47 0.82
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.54 0.81 1.47 0.82
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.54 0.81 1.47 0.82
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.60 0.89 1.72 0.82
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with IPXL

Latest IPXL Headlines from TheStreet

More Financial News for IPXL

Press Releases for IPXL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter